Dimed S.A. Distribuidora de Medicamentos

BOVESPA:PNVL3 Stock Report

Market Cap: R$1.4b

Dimed Distribuidora de Medicamentos Past Earnings Performance

Past criteria checks 5/6

Dimed Distribuidora de Medicamentos has been growing earnings at an average annual rate of 8.2%, while the Consumer Retailing industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 13.5% per year. Dimed Distribuidora de Medicamentos's return on equity is 8.7%, and it has net margins of 2.1%.

Key information

8.2%

Earnings growth rate

6.6%

EPS growth rate

Consumer Retailing Industry Growth9.2%
Revenue growth rate13.5%
Return on equity8.7%
Net Margin2.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Nov 17
Dimed S.A. Distribuidora de Medicamentos Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

Nov 04
Investors Could Be Concerned With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Returns On Capital

These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Jul 12
These 4 Measures Indicate That Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Using Debt Extensively

Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

May 27
Investors Shouldn't Be Too Comfortable With Dimed Distribuidora de Medicamentos' (BVMF:PNVL3) Robust Earnings

Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Apr 15
Be Wary Of Dimed Distribuidora de Medicamentos (BVMF:PNVL3) And Its Returns On Capital

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

Mar 25
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Seems To Use Debt Quite Sensibly

The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Jan 06
The Returns On Capital At Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Don't Inspire Confidence

Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Oct 23
Dimed S.A. Distribuidora de Medicamentos' (BVMF:PNVL3) Stock Retreats 26% But Earnings Haven't Escaped The Attention Of Investors

Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Aug 15
Dimed Distribuidora de Medicamentos (BVMF:PNVL3) Is Reinvesting At Lower Rates Of Return

Revenue & Expenses Breakdown

How Dimed Distribuidora de Medicamentos makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BOVESPA:PNVL3 Revenue, expenses and earnings (BRL Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,8181041,3400
30 Jun 244,712911,3060
31 Mar 244,6601081,2720
31 Dec 234,461931,2100
30 Sep 234,325881,1660
30 Jun 234,211831,1470
31 Mar 234,116841,1250
31 Dec 223,990861,0990
30 Sep 223,799851,0560
30 Jun 223,584839950
31 Mar 223,375809420
31 Dec 213,225799070
30 Sep 213,135798600
30 Jun 213,032798250
31 Mar 212,878627700
31 Dec 202,819567260
30 Sep 202,764567180
30 Jun 202,754627040
31 Mar 202,780786990
31 Dec 192,725776870
30 Sep 192,638806580
30 Jun 192,562796420
31 Mar 192,500766260
31 Dec 182,432756090
30 Sep 182,359656010
30 Jun 182,317595890
31 Mar 182,282595800
31 Dec 172,258605710
30 Sep 172,238605560
30 Jun 172,191595480
31 Mar 172,146575680
31 Dec 162,129535580
30 Sep 162,095535390
30 Jun 162,074505220
31 Mar 162,043504760
31 Dec 151,986454620
30 Sep 151,963444470
30 Jun 151,927434360
31 Mar 151,916484320
31 Dec 141,887494240
30 Sep 141,835504270
30 Jun 141,823584140
31 Mar 141,786553900
31 Dec 131,740563790

Quality Earnings: PNVL3 has high quality earnings.

Growing Profit Margin: PNVL3's current net profit margins (2.1%) are higher than last year (2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PNVL3's earnings have grown by 8.2% per year over the past 5 years.

Accelerating Growth: PNVL3's earnings growth over the past year (17.6%) exceeds its 5-year average (8.2% per year).

Earnings vs Industry: PNVL3 earnings growth over the past year (17.6%) exceeded the Consumer Retailing industry 14.3%.


Return on Equity

High ROE: PNVL3's Return on Equity (8.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies